Skip to main content

Dr. James A. Dailey, M.D.

Physical Medicine & Rehabilitation (PM&R) (Physical Medicine & Rehabilitation Physician)

  • Medicare participating

At a glance

Years since graduation
16
In the NPI registry since
2010
Medicare patients seen, 2024
372

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2010Medical school: Brody School of Medicine at East Carolina University
  • 2010Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Physical Medicine & Rehabilitation Physician primary
    VA license 010125803
  • Pain Medicine Physician
    VA license 010125803

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Physical Medicine & Rehabilitation (PM&R) per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
372
Services billed
12,038
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml3,046202
Injection, dexamethasone sodium phosphate, 1 mg1,932136
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml1,728131
Injection, triamcinolone acetonide, not otherwise specified, 10 mg1,349189
Established patient office or other outpatient visit, 30-39 minutes973327
Injection of substance into lower spine canal using imaging guidance16196
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level14292
New patient office or other outpatient visit, 45-59 minutes128128
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level10861
Fluoroscopic guidance for needle placement9361

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 1 companies reported 22 payments worth $1,597 in total to this clinician.

By company
Medtronic, Inc.$1,597
By type
Food and Beverage$849
Travel and Lodging$748

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Feb 18, 2025Medtronic, Inc.
Feb 18, 2025
Travel and Lodging
SYNCHROMEDII · Drug Infusion Systems · travel to Washington D.C., DC · in-kind
$432
Feb 28, 2025Medtronic, Inc.
Feb 28, 2025
Travel and Lodging
SYNCHROMEDII · Drug Infusion Systems · travel to Washington D.C., DC · in-kind
$219
Feb 18, 2025Medtronic, Inc.
Feb 18, 2025
Travel and Lodging
SYNCHROMEDII · Drug Infusion Systems · travel to Washington D.C., DC · in-kind
$35.07
Feb 28, 2025Medtronic, Inc.
Feb 28, 2025
Travel and Lodging
SYNCHROMEDII · Drug Infusion Systems · travel to Washington D.C., DC · in-kind
$34.93
Feb 21, 2025Medtronic, Inc.
Feb 21, 2025
Travel and Lodging
SYNCHROMEDII · Drug Infusion Systems · travel to Washington D.C., DC · in-kind
$27.14

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Virginia →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $114,061 in research payments for these studies, mostly to the institutions running them.

  • A phase 3, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of retatrutide once weekly in participants who have obesity or overweight and chronic low back pain (TRIUMPH-7)
    Eli Lilly and Company

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Physical Medicine & Rehabilitation (PM&R) clinicians in Danville

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 10, 2020), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1720308471. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.